FOLH1 and posterior cortical atrophy: In this phase 2 trial patients with PLN oligorecurrence (≤5 nodes) identified on PET/CT (83% PSMA, 17% choline) after radical therapy for PCa were randomized to either MDT (n = 97), or ENRT+MDT (n = 93), both arms receiving 6 months of ADT.